Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Several psychopharmacological agents induce weight gain. Recent studies have suggested that the tumor necrosis factor-alpha (TNF-alpha) cytokine system is pathophysiologically involved. To assess whether carbamazepine and lithium, which have been reported to lead to weight gain, have effects on the circulating levels of cytokines, we measured plasma levels of TNF-alpha, its soluble receptors sTNF-R p55 and p75, and leptin, as well as weight in 25 inpatients receiving lithium (n=10) or carbamazepine (n=15) weekly during the first 4 weeks of treatment. We found an increase in the body mass index and in TNF-alpha and its soluble receptor levels, but not in leptin levels over the 4 weeks of treatment. These changes did not differ between treatment groups. Changes of weight during the first week of treatment, but no other parameter, strongly predicted weight change until endpoint. We conclude that the mood stabilizers carbamazepine and lithium have similar effects on the TNF-alpha system and do not affect leptin levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some of these mood stabilizers, for example lithium and carbamazepine, have also been shown to lead to weight gain as well as an increase in pro-inflammatory cytokine levels (206).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [206]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518 · cited 1×
“TNF-α is produced by monocytes, macrophages, but also by fat cells, which express TNF-α and both TNF receptors (sTNF-R p55 and sTNF-R p75) ( Hotamisligil et al. 1993 ).”
BackgroundCentral nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · cited 1×
“Leptin signals to the brain the size of the adipose tissue (Schwartz et al. 2000).”
BackgroundWhat Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862 · cited 1×
“Treatment of patients suffering from affective disorders with mood stabilizers such as lithium ( Bauer and Mitchner 2004 ) and carbamazepine (Post et al.1998) typically covers years and sometimes decades (Berghofer et al. 1996; Mendlewicz et al. 1999).”
BackgroundZimmermann, U., Kraus, T., Himmerich, H., Schuld, A., & Pollmächer, T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00018-9 · Cited by 347 · cited 3×
“Hence, these mood stabilizers, which are already known to induce weight gain (Zimmermann et al. 2003), also equally activate the TNF-α system.”
BackgroundInfluentialSelf-citationHaack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329 · cited 1×
“Regarding the TNF-α system, lithium demonstrated significant immunoregulatory effects by increasing the in vitro production of TNF-α in healthy volunteers (Maes et al. 1999), and the TNF-α and sTNF-R p75 levels have already been shown to be significantly increased cross-sectionally in patients treated with lithium ( H…”
BackgroundSelf-citationMelkersson, K., & Dahl, M.-L. (2004) · Drugs · doi:10.2165/00003495-200464070-00003 · Cited by 247
Effects of Clozapine on Plasma Cytokine and Soluble Cytokine Receptor Levels
Pollmacher, T., Hinze-Selch, D., & Mullington, J. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00011 · Cited by 232 · cited 3×
“In contrast, drugs that have no or even a negative effect onweight, such as haloperidol, paroxetine, and venlafaxine, did not influence the TNF-α system (Hinze-Selch et al. 2000; Kraus et al. 1999, 2002; Pollmächer et al. 1996; Schuld et al. 2000).”
BackgroundSelf-citationZhang, Z.-J., Yao, Z.-J., Liu, W., Fang, Q., & Reynolds, G. P. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.1.58 · Cited by 230 · cited 1×
“Zhang et al. (2004) reported a threefold”
Body Weight and Leptin Plasma Levels During Treatment With Antipsychotic Drugs
Kraus, T., Haack, M., Schuld, A., Hinze-Selch, D., K�hn, M., Uhr, M., & Pollm�cher, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.312 · Cited by 221 · cited 2×
“This has been clearly shown for the second-generation antipsychotics, olanzapine and clozapine (Kraus et al. 1999; Schuld et al. 2000).”
BackgroundSelf-citationHinze‐Selch, D. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00089-0 · Cited by 157 · cited 3×
“In contrast, drugsthat have no or even a negative effect onweight,suchashaloperidol,paroxetine,andvenlafaxine, did not influence the TNF-α system ( Hinze-Selch et al. 2000; Kraus et al. 1999, 2002; Pollmacher et al. 1996; Schuld et al. 2000).”
BackgroundInfluential
Research works printed but not linked: 1
- Schuld A, Kraus T, Haack M, Hinze-Selch D, Kühn M, Pollmächer T (2000) Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophr Res 102:1?3
Cited by
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375
“This result supports the idea that mood stabilizers for bipolar disorder have immunomodulatory effects and IL-6 is considered as a state marker of bipolar manic patients (Boufidou et al., 2004; Himmerich et al., 2005; Knijff et al., 2006; Maes et al., 1997a,b; Rapaport, 1994; Rapaport et al., 1999; Sluzewska et al., 1…”
ResultPadmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Self-citationCytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256
Metadata
- Authors
- Himmerich, H., Koethe, D., Schuld, A., Yassouridis, A., & Pollm�cher, T.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Klinikum Ingolstadt (DE)
- Venue
- Psychopharmacology
- Published
- 2004-11-25
- Volume
- 179
- Issue
- 2
- Pages
- 447-451
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2057356180
- Cited by
- 60
- References
- 31
- Citations by year
- 2024: 1 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 1
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- leptin, TNF-α, soluble TNF receptors, carbamazepine, lithium, weight gain, mood stabilizers, body mass index, cytokines, immunomodulators, antiepileptic drugs
- MeSH terms
- Adult, Bipolar Disorder, Body Weight, Carbamazepine, Female, Humans, Immunologic Factors, Male, Middle Aged, Tumor Necrosis Factor-alpha, Body Mass Index, Lithium Carbonate, Receptors, Tumor Necrosis Factor, Antimanic Agents, Mood Disorders, Leptin, Receptors, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. https://app.cochat.ai/papers/10.1007/s00213-004-2038-9
- The paper
- Himmerich, H., Koethe, D., Schuld, A., Yassouridis, A., & Pollm�cher, T. (2005). Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology. https://doi.org/10.1007/s00213-004-2038-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.